{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:13:12Z","timestamp":1778004792097,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00223-016-0132-8","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T03:58:10Z","timestamp":1458878290000},"page":"131-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX\u00ae in Portugal"],"prefix":"10.1007","volume":"99","author":[{"given":"Andr\u00e9a","family":"Marques","sequence":"first","affiliation":[]},{"given":"\u00d3scar","family":"Louren\u00e7o","sequence":"additional","affiliation":[]},{"given":"Gustaf","family":"Orts\u00e4ter","sequence":"additional","affiliation":[]},{"given":"Fredrik","family":"Borgstr\u00f6m","sequence":"additional","affiliation":[]},{"given":"John A.","family":"Kanis","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Ant\u00f3nio P.","family":"da Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,3,25]]},"reference":[{"issue":"9","key":"132_CR1","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239\u20132256. doi: 10.1007\/s00198-012-1964-3","journal-title":"Osteoporos Int"},{"issue":"1\u20132","key":"132_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos 8(1\u20132):136. doi: 10.1007\/s11657-013-0136-1","journal-title":"Arch Osteoporos"},{"issue":"8","key":"132_CR3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton Iii LJ, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, Van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033\u20131046","journal-title":"Osteoporos Int"},{"issue":"4","key":"132_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385\u2013397. doi: 10.1007\/s00198-007-0543-5","journal-title":"Osteoporos Int"},{"issue":"9","key":"132_CR5","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00198-011-1713-z","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22(9):2395\u20132411. doi: 10.1007\/s00198-011-1713-z","journal-title":"Osteoporos Int"},{"issue":"1","key":"132_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23\u201357. doi: 10.1007\/s00198-012-2074-y","journal-title":"Osteoporos Int"},{"issue":"10","key":"132_CR7","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A (2008) Case finding for the management of osteoporosis with FRAX\u2014assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395\u20131408. doi: 10.1007\/s00198-008-0712-1","journal-title":"Osteoporos Int"},{"issue":"4","key":"132_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","volume":"19","author":"AN Tosteson","year":"2008","unstructured":"Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437\u2013447. doi: 10.1007\/s00198-007-0550-6","journal-title":"Osteoporos Int"},{"issue":"11","key":"132_CR9","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s00198-011-1869-6","volume":"23","author":"K Lippuner","year":"2012","unstructured":"Lippuner K, Johansson H, Borgstrom F, Kanis JA, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX(R) in Switzerland. Osteoporos Int 23(11):2579\u20132589. doi: 10.1007\/s00198-011-1869-6","journal-title":"Osteoporos Int"},{"issue":"7","key":"132_CR10","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s00198-015-3055-8","volume":"26","author":"P Makras","year":"2015","unstructured":"Makras P, Athanasakis K, Boubouchairopoulou N, Rizou S, Anastasilakis AD, Kyriopoulos J, Lyritis GP (2015) Cost-effective osteoporosis treatment thresholds in Greece. Osteoporos Int 26(7):1949\u20131957. doi: 10.1007\/s00198-015-3055-8","journal-title":"Osteoporos Int"},{"issue":"2","key":"132_CR11","first-page":"104","volume":"38","author":"A Marques","year":"2013","unstructured":"Marques A, Mota A, Canhao H, Romeu JC, Machado P, Ruano A, Barbosa AP, Dias AA, Silva D, Araujo D, Simoes E, Aguas F, Rosendo I, Silva I, Crespo J, Alves JD, Costa L, Mascarenhas M, Lourenco O, Ferreira PL, Lucas R, Roque R, Branco JC, Tavares V, Johansson H, Kanis J, Pereira da Silva JA (2013) A FRAX model for the estimation of osteoporotic fracture probability in Portugal. Acta Reumatol Port 38(2):104\u2013112","journal-title":"Acta Reumatol Port"},{"issue":"2","key":"132_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11136-013-0488-4","volume":"23","author":"LN Ferreira","year":"2013","unstructured":"Ferreira LN, Ferreira PL, Pereira LN, Oppe M (2013) EQ-5D Portuguese population norms. Qual Life Res 23(2):425\u2013430. doi: 10.1007\/s11136-013-0488-4","journal-title":"Qual Life Res"},{"key":"132_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3171-5","author":"A Marques","year":"2015","unstructured":"Marques A, Lourenco O, da Silva JA (2015) The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality. Osteoporos Int. doi: 10.1007\/s00198-015-3171-5","journal-title":"Osteoporos Int"},{"issue":"3","key":"132_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00198-010-1291-5","volume":"22","author":"F Borgstrom","year":"2011","unstructured":"Borgstrom F, Strom O, Kleman M, McCloskey E, Johansson H, Oden A, Kanis JA (2011) Cost-effectiveness of bazedoxifene incorporating the FRAX(R) algorithm in a European perspective. Osteoporos Int 22(3):955\u2013965. doi: 10.1007\/s00198-010-1291-5","journal-title":"Osteoporos Int"},{"issue":"3","key":"132_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00198-010-1424-x","volume":"22","author":"B Jonsson","year":"2011","unstructured":"Jonsson B, Strom O, Eisman JA, Papaioannou A, Siris ES, Tosteson A, Kanis JA (2011) Cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int 22(3):967\u2013982. doi: 10.1007\/s00198-010-1424-x","journal-title":"Osteoporos Int"},{"issue":"4","key":"132_CR16","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00198-012-2115-6","volume":"24","author":"O Strom","year":"2013","unstructured":"Strom O, Jonsson B, Kanis JA (2013) Intervention thresholds for denosumab in the UK using a FRAX(R)-based cost-effectiveness analysis. Osteoporos Int 24(4):1491\u20131502. doi: 10.1007\/s00198-012-2115-6","journal-title":"Osteoporos Int"},{"key":"132_CR17","unstructured":"Jones ML, Wilkinson A (2006) Adverse effects and persistence with therapy in patients taking oral alendronate, etidronate or risedronate: systematic reviews (NICE). The University of Sheffield, School of Health and Related Research. http:\/\/www.nice.org.uk\/guidance\/index.jsp?action=download&o=36718 . Accessed 5 Jan 2015"},{"issue":"12","key":"132_CR18","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00198-008-0623-1","volume":"19","author":"MF Pina de","year":"2008","unstructured":"de Pina MF, Alves SM, Barbosa M, Barros H (2008) Hip fractures cluster in space: an epidemiological analysis in Portugal. Osteoporos Int 19(12):1797\u20131804. doi: 10.1007\/s00198-008-0623-1","journal-title":"Osteoporos Int"},{"issue":"8","key":"132_CR19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s001980070064","volume":"11","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11(8):669\u2013674","journal-title":"Osteoporos Int"},{"issue":"3","key":"132_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00198-009-0989-8","volume":"21","author":"F Borgstrom","year":"2010","unstructured":"Borgstrom F, Strom O, Coelho J, Johansson H, Oden A, McCloskey EV, Kanis JA (2010) The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX. Osteoporos Int 21(3):495\u2013505. doi: 10.1007\/s00198-009-0989-8","journal-title":"Osteoporos Int"},{"issue":"6","key":"132_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s001980050105","volume":"8","author":"A Oden","year":"1998","unstructured":"Oden A, Dawson A, Dere W, Johnell O, Jonsson B, Kanis JA (1998) Lifetime risk of hip fractures is underestimated. Osteoporos Int 8(6):599\u2013603. doi: 10.1007\/s001980050105","journal-title":"Osteoporos Int"},{"issue":"1","key":"132_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00198-003-1490-4","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B (2004) Mortality after osteoporotic fractures. Osteopor Int 15(1):38\u201342. doi: 10.1007\/s00198-003-1490-4","journal-title":"Osteopor Int"},{"issue":"1","key":"132_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00198-013-2521-4","volume":"25","author":"K Kim","year":"2014","unstructured":"Kim K, Svedbom A, Luo X, Sutradhar S, Kanis JA (2014) Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm. Osteoporos Int 25(1):325\u2013337. doi: 10.1007\/s00198-013-2521-4","journal-title":"Osteoporos Int"},{"issue":"19","key":"132_CR24","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/nejm200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434\u20131441. doi: 10.1056\/nejm200105103441904","journal-title":"N Engl J Med"},{"issue":"1","key":"132_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2007.10.019","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Adams J, Borgstrom F, Cooper C, Jonsson B, Preedy D, Selby P, Compston J (2008) The cost-effectiveness of alendronate in the management of osteoporosis. Bone 42(1):4\u201315. doi: 10.1016\/j.bone.2007.10.019","journal-title":"Bone"},{"issue":"1","key":"132_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","volume":"23","author":"N Freemantle","year":"2012","unstructured":"Freemantle N, Satram-Hoang S, Tang ET, Kaur P, Macarios D, Siddhanti S, Borenstein J, Kendler DL (2012) Final results of the DAPS (denosumab adherence preference satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int 23(1):317\u2013326. doi: 10.1007\/s00198-011-1780-1","journal-title":"Osteoporos Int"},{"issue":"18","key":"132_CR27","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809\u20131822. doi: 10.1056\/NEJMoa067312","journal-title":"N Engl J Med"},{"issue":"8","key":"132_CR28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756\u2013765. doi: 10.1056\/NEJMoa0809493","journal-title":"N Engl J Med"},{"issue":"10","key":"132_CR29","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00198-006-0107-0","volume":"17","author":"F Borgstrom","year":"2006","unstructured":"Borgstrom F, Johnell O, Kanis JA, Jonsson B, Rehnberg C (2006) At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int 17(10):1459\u20131471. doi: 10.1007\/s00198-006-0107-0","journal-title":"Osteoporos Int"},{"issue":"1","key":"132_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00198-003-1463-7","volume":"15","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B (2004) The risk and burden of vertebral fractures in Sweden. Osteoporos Int 15(1):20\u201326. doi: 10.1007\/s00198-003-1463-7","journal-title":"Osteoporos Int"},{"issue":"3","key":"132_CR31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1467-9884.00093","volume":"46","author":"P Royston","year":"1997","unstructured":"Royston P, Altman DG (1997) Approximating statistical functions by using fractional polynomial regression. J Roy Stat Soc 46(3):411\u2013422","journal-title":"J Roy Stat Soc"},{"issue":"12","key":"132_CR32","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1016\/j.csda.2005.07.015","volume":"50","author":"W Sauerbrei","year":"2006","unstructured":"Sauerbrei W, Meier-Hirmer C, Benner A, Royston P (2006) Multivariable regression model building by using fractional polynomials: description of SAS, STATA and R programs. Comput Stat Data Anal 50(12):3464\u20133485","journal-title":"Comput Stat Data Anal"},{"issue":"9","key":"132_CR33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","volume":"26","author":"C McCabe","year":"2008","unstructured":"McCabe C, Claxton K, Culyer AJ (2008) The NICE cost-effectiveness threshold. Pharmacoeconomics 26(9):733\u2013744","journal-title":"Pharmacoeconomics"},{"key":"132_CR34","unstructured":"Kanis J (2008) Assessment of osteoporosis at the primary healthcare level. Technical Report, p61, WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield"},{"key":"132_CR35","unstructured":"European Commission Economic and Financial Affairs. http:\/\/ec.europa.eu\/economy_finance\/ameco\/user\/serie\/ResultSerie.cfm . Accessed 7 Feb 2015"},{"issue":"14","key":"132_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta19140","volume":"19","author":"K Claxton","year":"2015","unstructured":"Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M (2015) Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess 19(14):1\u2013503v\u2013vi. doi: 10.3310\/hta19140","journal-title":"Health Technol Assess"},{"issue":"11","key":"132_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.7326\/0003-4819-155-11-201112060-00007","volume":"155","author":"S Nayak","year":"2011","unstructured":"Nayak S, Roberts MS, Greenspan SL (2011) Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann Intern Med 155(11):751\u2013761. doi: 10.7326\/0003-4819-155-11-201112060-00007","journal-title":"Ann Intern Med"},{"issue":"2","key":"132_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jbmr.1758","volume":"28","author":"L Nshimyumukiza","year":"2013","unstructured":"Nshimyumukiza L, Durand A, Gagnon M, Douville X, Morin S, Lindsay C, Duplantie J, Gagne C, Jean S, Giguere Y, Dodin S, Rousseau F, Reinharz D (2013) An economic evaluation: simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures. J Bone Miner Res 28(2):383\u2013394. doi: 10.1002\/jbmr.1758","journal-title":"J Bone Miner Res"},{"issue":"1","key":"132_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00198-013-2551-y","volume":"25","author":"L Si","year":"2014","unstructured":"Si L, Winzenberg TM, Palmer AJ (2014) A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures. Osteoporos Int 25(1):51\u201360. doi: 10.1007\/s00198-013-2551-y","journal-title":"Osteoporos Int"},{"issue":"6","key":"132_CR40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16(6):581\u2013589. doi: 10.1007\/s00198-004-1780-5","journal-title":"Osteoporos Int"},{"issue":"3","key":"132_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jbspin.2012.02.014","volume":"79","author":"K Briot","year":"2012","unstructured":"Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM, Gauvain JB, Guggenbuhl P, Kolta S, Lespessailles E, Letombe B, Marcelli C, Orcel P, Seret P, Tremollieres F, Roux C (2012) 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine 79(3):304\u2013313. doi: 10.1016\/j.jbspin.2012.02.014","journal-title":"Joint Bone Spine"},{"issue":"10","key":"132_CR42","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381. doi: 10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"issue":"3","key":"132_CR43","first-page":"195","volume":"10","author":"GL Colombo","year":"2013","unstructured":"Colombo GL, Montecucco CM (2013) Generic vs brand originator alendronate: analysis of persistence and compliance in five Local Healthcare Units in the Lombardy Region of Italy. Clin Cases Miner Bone Metab 10(3):195\u2013198","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"2","key":"132_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00296-009-0940-5","volume":"30","author":"JD Ringe","year":"2009","unstructured":"Ringe JD, Moller G (2009) Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. Rheumatol Int 30(2):213\u2013221. doi: 10.1007\/s00296-009-0940-5","journal-title":"Rheumatol Int"},{"issue":"3","key":"132_CR45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00223-009-9329-4","volume":"86","author":"M Hiligsmann","year":"2010","unstructured":"Hiligsmann M, Rabenda V, Gathon HJ, Ethgen O, Reginster JY (2010) Potential clinical and economic impact of nonadherence with osteoporosis medications. Calcif Tissue Int 86(3):202\u2013210","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"132_CR46","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s00198-014-2777-3","volume":"25","author":"K Siggeirsdottir","year":"2014","unstructured":"Siggeirsdottir K, Aspelund T, Johansson H, Gudmundsson EF, Mogensen B, Jonsson BY, Gudnason V, McCloskey E, Oden A, Sigurdsson G, Kanis JA (2014) The incidence of a first major osteoporotic fracture in Iceland and implications for FRAX. Osteoporos Int 25(10):2445\u20132451. doi: 10.1007\/s00198-014-2777-3","journal-title":"Osteoporos Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-016-0132-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0132-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T19:45:53Z","timestamp":1600371953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-016-0132-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,25]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1007\/s00223-016-0132-8","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,25]]}}}